CD37 inhibition suppresses lung metastasis originating from melanoma through the induction of expansion of CD11b+Gr-1hi myeloid cells and enhancing the synthesis of TNF-α and interleukin 1β (IL-1β) [24]. This evidence concerns the gene IL1B and melanoma.